Search

Your search keyword '"Adegbola, Richard A"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Adegbola, Richard A" Remove constraint Author: "Adegbola, Richard A" Database Unpaywall Remove constraint Database: Unpaywall
199 results on '"Adegbola, Richard A"'

Search Results

1. Whole genome sequencing and phylogenetic analysis of SARS-CoV-2 strains isolated during the COVID-19 pandemic in Nigeria

2. Invasive bacterial disease in young infants in rural Gambia: Population-based surveillance

4. Multidrug-Resistant Kocuria rosea and Methicillin-Resistant Staphylococcus aureus Co-Infection in a Nigerian Patient with COVID-19: A Case Report

5. Prevalence and spatiotemporal distribution of rotavirus diarrhea among children younger than five years old in Lagos, Nigeria

6. Significance of hematologic abnormalities in COVID-19 severity among infected patients in Lagos, Nigeria

7. SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa

8. Standardization of Epidemiological Surveillance of Invasive Group A Streptococcal Infections

9. Childhood meningitis in rural Gambia: 10 years of population-based surveillance

10. SARS-CoV-2 Antibody Responses to AZD1222 Vaccination in West Africa

11. COVID-19 vaccine breakthrough infections among fully vaccinated Health Care Workers in Lagos, Nigeria

12. Antibody responses to AZD1222 vaccination in West Africa

13. Evaluation of respiratory tract bacterial co-infections in SARS-CoV-2 patients with mild or asymptomatic infection in Lagos, Nigeria

14. Childhood meningitis in rural Gambia: 10 years of population-based surveillance

15. Widespread sharing of pneumococcal strains in a rural African setting: proximate villages are more likely to share similar strains that are carried at multiple timepoints

16. Outcome of Symptom-Based RT-PCR Testing for SARS-CoV-2: Experience from a Large Public Testing Centre in Nigeria

17. The use of DIY (Do it yourself) sampling and telemonitoring model for COVID-19 qPCR testing scale up

18. SARS-CoV-2 sequencing collaboration in west Africa shows best practices

19. Pathogens Associated With Linear Growth Faltering in Children With Diarrhea and Impact of Antibiotic Treatment: The Global Enteric Multicenter Study

20. Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance

22. Improving the Understanding of the Immunopathogenesis of Lymphopenia as a Correlate of SARS-CoV-2 Infection Risk and Disease Progression in African Patients: Protocol for a Cross-sectional Study

23. Comparative performance of SARS-CoV-2 real-time PCR diagnostic assays on samples from Lagos, Nigeria

24. Carriage Dynamics of Pneumococcal Serotypes in Naturally Colonized Infants in a Rural African Setting During the First Year of Life

27. Within-host microevolution of Streptococcus pneumoniae is rapid and adaptive during natural colonisation

28. Persistent and Emerging Pneumococcal Carriage Serotypes in a Rural Gambian Community After 10 Years of Pneumococcal Conjugate Vaccine Pressure

29. Improving the Understanding of the Immunopathogenesis of Lymphopenia as a Correlate of SARS-CoV-2 Infection Risk and Disease Progression in African Patients: Protocol for a Cross-sectional Study (Preprint)

31. COVID-19 Spread Patterns Is Unrelated to Malaria Co-Infections in Lagos, Nigeria

32. Cryptosporidium infection in rural Gambian children: Epidemiology and risk factors

33. Staphylococcus aureus Bacteremia in Children of Rural Areas of The Gambia, 2008–2015

34. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS)

36. Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis

37. Zinc as an adjunct therapy in the management of severe pneumonia among Gambian children: randomized controlled trial

38. Identification of Subsets of Enteroaggregative Escherichia coli Associated with Diarrheal Disease among Under 5 Years of Age Children from Rural Gambia

39. Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies

40. Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology

41. The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance

42. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study

43. The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)

45. Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age

46. Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years

47. Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine

Catalog

Books, media, physical & digital resources